Mild Behavioral Impairment an Early Indicator of Alzheimer’s

Based in Atlanta, Eugene E. Houchins III is the founder and president of the American Life Fund Corp, a company that offers pathways to funds for people with life-threatening conditions. Eugene E. Houchins III is particularly interested in cancer research and Alzheimer’s disease research.

According to recent research conducted at the McGill University Research Centre for Studies in Aging, a correlation exists between mild behavioral impairment (MBI) and Alzheimer’s disease. The noncognitive symptoms of MBI typically occur among individuals who are still cognitively healthy.

The study found that MBI is strongly associated with amyloid plaques in the brain, which is an initial pathological change associated with the early stages of Alzheimer’s. These specific proteins are associated with abnormal human behavior such as MBI, which can subsequently manifest as memory loss.

By using an MBI checklist, physicians may be able to identify people who are at a higher risk of dementia even before symptoms begin to manifest. The result will be treatment at earlier stages of Alzheimer’s progression, which may have a greater chance of slowing or reversing the disease.

Promising Results for New Alzheimer’s Treatments

Well-versed in insurance, entrepreneur Eugene E. Houchins III serves as president and CEO of American Life Fund Corp. With his company, Eugene E. Houchins III helps patients who are suffering from serious illnesses to access funds from their life insurance policies, helping them cover living and medical expenses. Aside from his professional duties, he is a supporter of philanthropic organizations contributing to research on diseases like cancer and Alzheimer’s disease.

Alzheimer’s disease is a progressive brain disorder that causes individuals to lose thinking skills, memory, and eventually the ability to perform simple tasks. There is currently no cure for Alzheimer’s disease, and it is irreversible once it begins to progress.

Because of the complexity of Alzheimer’s disease, doctors tend to treat Alzheimer’s by focusing on slowing down the progression and symptoms, managing any behavioral symptoms, and helping to maintain mental function as much as possible. There are several prescription drugs available that can help manage symptoms in the early to middle stages of the disease. As the disease progresses, some people find drugs called cholinesterase inhibitors effective in reducing symptoms and controlling behavioral issues that can arise.

Alzheimer’s disease is thought to be caused in part by a buildup of a particular protein known as beta-amyloid in the brain. In 2019, researchers at the University of Southern California in Los Angeles began exploring a new compound called 3K3A-APC, a modified activated C protein. Activated C protein protects the blood vessels and brain cells from damage caused by inflammation. This new compound, 3K3A-APC, has shown promise in trials for other brain diseases, so researchers decided to try this with Alzheimer’s disease as well. More research is likely on the horizon to see how effective this treatment may be.

Three Tips for New Little League Coaches

Leading American Life Fund Corp in Atlanta, Georgia, established businessman and entrepreneur Eugene E. Houchins III is focused on making sure those holding life insurances policies can have timely access to funds to pay for daily expenses and the treatment of serious illnesses. Outside of his professional interests, Eugene E. Houchins III is a college football fan and has coached young sports teams, including Little League.

Many sports organizations for young players rely on volunteers to serve as coaches for the teams. If you’re thinking of serving as a Little League coach for any sport, here are some quick tips to follow to make your first time easier.

1. Review your rulebook. No matter what sport you are coaching, there will be a rulebook available to you. You should not only review this before the season starts, but also during the season in order to stay fresh on the rules and regulations.

2. Work up some practice plans. This will help you to stay organized throughout the season and keep your team on track. Remember that Little League teams are focused on development, so you’ll need to organize your practices to teach the fundamentals of your sport.

3. Let the kids have fun. Little League is for the kids, and kids should enjoy their first experience with sports. Make sure that you work some fun into your practice sessions. You could try letting the kids end practice with a scrimmage or another fun, team-building exercise. Running practices with military precision likely won’t be successful when working with young kids, so keep the age level in mind.

New Treatment Could Increase Survival Rates after Chemotherapy

Through his firm American Life Fund Corp., Eugene E. Houchins III helps his clients gain access to funds needed for things such as uninsured medical costs. Eugene E. Houchins III takes a professional interest in innovations that could improve the survival rate of cancer patients.

Persons with lymphoma and leukemia may one day benefit from new research that suggests using existing drugs to fight cancer in a new and potentially much more effective way can increase survival rates.

No method now exists for curing or removing these cancers. Patients often receive chemotherapy with the goal of killing all cancer cells, staving off the disease. Unfortunately, cancer cells often develop resistance to chemo during treatment, and the tumors are not eradicated.

Researchers are now looking at a class of drugs known as small molecule inhibitors that takes advantage of cancer cells’ need for healthy adjacent cells (called stroma cells) to survive. Isolating the stroma cells from the tumor robs it of necessary nutrients and the cancer cells die.

Until now, scientists have not known how to accomplish this, but a recent study demonstrates that proteins known as PKC-inhibitors can starve tumor cells by affecting the stromas. Previous researchers who attempted to strike cancer cells directly with PKC saw poor results.

Treating both tumor and stroma cells improved survival rates considerably – in one case extending the period by 90 percent when compared to targeting tumors only. It had the added benefit of fighting several types of leukemia and lymphoma.

If other researchers can replicate these results, the outlook for patients with lymphoma and leukemia will be brighter.